Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.5 SEK | +0.69% | -5.76% | +24.52% |
May. 16 | Ambea Completes SEK187 Million Share Buyback; New Program Set to Launch | MT |
May. 15 | Ambea AB Approves Dividend, Payable on 22 May 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.64 for the current year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.52% | 530M | B- | ||
+19.28% | 84.56B | C+ | ||
-26.95% | 72.41B | B- | ||
+4.65% | 27.75B | C+ | ||
-7.35% | 17.75B | B | ||
+4.69% | 16.03B | A- | ||
+8.14% | 13.72B | B- | ||
+69.96% | 13.07B | C- | ||
+6.59% | 12.91B | A- | ||
+70.00% | 12.55B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AMBEA Stock
- Ratings Ambea AB